I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Canada

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology AMP 2023
Roche at

AMP 2023

November 14 - November 18
Salt Lake City, USA
amp23.amp
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Nov 17 / Roche
Circulating tumor DNA-based characterization of copy number and structural variants in diffuse large B-cell lymphoma by targeted hybrid-capture based deep sequencing
The authors assess the feasibility of the KAPA NHL Panel to detect copy number variants and stuctural variants in diffuse large B-cell lymphoma from circulating tumor DNA isolated from plasma samples. This abstract has been previously published in J Mol Diagn (https://doi.org/10.1016/S1525-1578(23)00249-0) as part of the Association for Molecular Pathology 2023 Annual Meeting Abstracts.
Oncology Diffuse large B cell lymphoma AMP-2023

Sign up or login to unlock the full suite of MEDICALLY features
Nov 17 / Roche
Tumor-specific somatic variant detection in cfDNA: ability of the AVENIOⓇ Surveillance test to detect low level allelic fraction ctDNA variants in colorectal cancer patient plasma samples
In this poster, the authors present the validity and concordance of a next-generation liquid biopsy assay, the AVENIOⓇ Oncology Assay Surveillance Test, to detect extremely low level allelic fraction circulating tumor DNA variants in cell-free DNA in colorectal cancer patient plasma samples. This abstract has been previously published in J Mol Diagn (https://doi.org/10.1016/S1525-1578(23)00249-0) as part of the Association for Molecular Pathology 2023 Annual Meeting Abstracts.
Oncology Colorectal Cancer AMP-2023

Sign up or login to unlock the full suite of MEDICALLY features
Nov 17 / Roche
Comparison study between multiple variant annotation software solutions
This work summarizes the analysis and comparison of genomic variant classifications across multiple commercially- or publicly-available digital solutions for variant interpretation, including navify Mutation Profiler. Sequencing data from real world cases were retrospectively analyzed through these annotation tools. By analyzing the similarities and differences in classifications and the underlying criteria employed by these various tools, the aim is to understand the nuances of each tool and guide researchers in selecting the most appropriate tool for their needs. This abstract has been previously published in J Mol Diagn (https://doi.org/10.1016/S1525-1578(23)00249-0) as part of the Association for Molecular Pathology 2023 Annual Meeting Abstracts.
Oncology Pan-tumour AMP-2023
04:15 PM
Duration 48hrs Salt Lake City, USA
Circulating tumor DNA-based characterization of copy number and structural variants in diffuse large B-cell lymphoma by targeted hybrid-capture based deep sequencing
Markus A, Chien R, Stokowski R, Agarwal P, Melnikova V, Richmond T, Blombery P
Oncology | Diffuse large B cell lymphoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 48hrs Salt Lake City, USA
Tumor-specific somatic variant detection in cfDNA: ability of the AVENIOⓇ Surveillance test to detect low level allelic fraction ctDNA variants in colorectal cancer patient plasma samples
Doshi J, Shabbeer J, Stokowski R
Oncology | Colorectal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 48hrs Salt Lake City, USA
Creation of a Robust Control for Use in Cell Free DNA Sequencing
Watve S, Doshi J, Ahmed A, Tareen S, Stokowski R, Li B, Shabbeer J
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 48hrs Salt Lake City, USA
MMSNP: A Novel Tool for Sample Cross-contamination Detection in Cell Free DNA Sequencing
Ahmed A, Gao S, Doshi J, Stokowski R, Shabbeer J, Li B
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 48hrs Salt Lake City, USA
Comparison study between multiple variant annotation software solutions
Khalife R, Sucheston-Campbell L, Sorensen H, Krishna S, Gholami A, Love T, Magliocco T
Oncology | Pan-tumour

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.